Life sciences leasing breaks annual record in five months

Mayor Bill de Blasio’s $500 million investment should spur more development

New York /
Jun.June 11, 2021 10:31 AM
The New York Life Sciences and Biotechnology Center at First Avenue and 41st Street (NY Life Sciences)

The New York Life Sciences and Biotechnology Center at First Avenue and 41st Street (NY Life Sciences)

Life sciences leasing in New York is going at full steam with no signs of stalling.

The sector topped an annual high this month with 257,000 square feet leased, far and above the 156,000 square feet rented in all of 2020, according to a CBRE analysis reported by the Commercial Observer.

Mayor Bill de Blasio said Wednesday that the city would throw at least another $500 million into life sciences development, bringing total investment up to $1 billion and signaling more expansion to come. Advocates have argued for years that the sector offers great potential for the city but needs a hand from government to reach a critical mass.

Most recently, Black Diamond Therapeutics signed a lease for 18,120 square feet at the Alexandria Center for Life Science, 430 East 29th Street. In addition to its office space at 180 Varick Street, the oncology medicine company will be basing its research group on part of the 11th floor. CBRE brokered the deal.

Life sciences had drawn significant interest before the pandemic, pulling $1.38 billion in funding in 2017. Leasing doubled between 2019 and 2020 and venture capital has raised at least $697 million annually for the past four years, according to the Commercial Observer.

But Covid-19 kicked investment into high gear. Venture capital, smelling potential, injected $393 million into the sector during the first quarter of 2021, a record for that period. Funding in the first two months of the second quarter hit $144 million, bringing year-to-date investment to $537 million, higher than it was at this time last year, the Commercial Observer reported.

Total venture capital funding in 2020 reached $942 million.

Tenants boosting New York’s life sciences growth include the Icahn School of Medicine at Mount Sinai, which is leasing 165,000 square feet at 787 11th Avenue. There’s also C16 Biosciences, a Bill Gates–backed startup, which signed a 19,000-square-foot lease at the Hudson Research Center, 619 West 54th Street.

[Commercial Observer] — Suzannah Cavanaugh





    Related Articles

    arrow_forward_ios
    Washington Prime Group CEO Lou Conforti (Twitter)
    Washington Prime Group files for Chapter 11 bankruptcy
    Washington Prime Group files for Chapter 11 bankruptcy
    Renderings of Greenpoint Landing in Greenpoint, 141 Willoughby Street in Downtown Brooklyn and 45-57 Davis Street in Long Island City (Photos via OMA, SLCE Architects and J Frankl Architects)
    These were the top outer-borough loans in May
    These were the top outer-borough loans in May
    RSA President Joseph Strasburg (Rent Stabilization Association)
    Landlords plea for water rate freeze ahead of vote
    Landlords plea for water rate freeze ahead of vote
    The commercial market was hit hard by the pandemic, and property tax revenue is expected to fall 5 percent. (iStock)
    Tax bills show how much Covid devalued NYC real estate
    Tax bills show how much Covid devalued NYC real estate
    Richard Segal of Seavest Investment Group, David Marx of Marx Development Group and 902 Quentin Road in Brooklyn (Photos via Seavest Investment Group, Marx Development Group and VRMNY)
    Westchester firm buys $54M Brooklyn medical building
    Westchester firm buys $54M Brooklyn medical building
    Real Estate EFTs See Investment Amid Pandemic Recovery
    Why investors are rushing into real estate ETFs
    Why investors are rushing into real estate ETFs
    Manhattan sublease surge shows signs of slowing
    Manhattan sublease scourge finally abates
    Manhattan sublease scourge finally abates
    Blooma founder Shayne Skaff (LinkedIn, iStock)
    CRE fintech startup Blooma nabs $15M in funding
    CRE fintech startup Blooma nabs $15M in funding
    arrow_forward_ios

    The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

    Loading...